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INTRODUCTION 
 
Paediatric cancers differ markedly from adult malignancies in their distribution by histology, tumour site and in 
prognosis. Acute lymphoblastic leukemia, brain cancers, Lymphomas and sarcomas of soft tissue and bone predominant in 
children and adolescence.3,8,72,73 Unlike incidence pattern in adults where cancer rates tend to rapidly increase with 
increasing age, relatively wide age variability exists during development, with two peaks in early childhood and in 
adolescence.16,17,19. 
 During the first year of life embryonal tumour such as neuroblastoma, nephroblastoma,  retinoblastoma, 
medulloblastoma, rhabdomyosarcoma, are most common.3,8,18,19,46,47 These embryonal tumours combine with acute 
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leukemia, NHL and gliomas which together peaks in incidence from 2 to 5yrs of age, for the highest cancer incidence 
during childhood and adolescence other than in infancy. It appears that adolescence is a transitional period between the 
common early childhood malignancies and characteristic carcinomas of adulthood. The mortality rate of cancer in children 
is approximately 3 to 5 deaths / 1 lakh population / year. 
 A number of genetic conditions associated with elevated risk of childhood cancers such as DOWNS SYNDROME, 
NF I and II, BECKWITH  WEIDEMANN SYNDROME, TUBEROUS SCLEROSIS and LI FRAUMENI SYNDROME. 
The risk factors for the major paediatric cancer includes ionizing radiation, non-ionizing power frequency electromagnetic 
field, pesticides, parental occupational chemical exposures, dietary factors and environmental cigarette smoke. The role of  
viruses such as polioma viruses, EBV & HTLV in etiologic importance is unclear. 
 In this study the paediatric cancers are broadly classified under 3 major groups i.e., soft tissue and bone sarcomas, 
Haematalogical and lymphoreticular malignancies and CNS neoplasms. Most authors and research workers agreed to follow 
this system in evaluating the incidence, prevalence, risk factors and management of pediatric cancers. In general, there is 
diversity in the occurrence of paediatric neoplasm all over the world. In this study, the actual incidence and presentation of 
paediatric neoplasm in semi urban area is evaluated with painful attention to clinical features, role of environmental factors, 
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consanguinity and initial cytomorphological evaluation with fine needle aspiration in proportion of cases. As Paediatric 
neoplasm are often anaplastic cancers, they pose a challenge to surgical pathologist. 
 Paediatric oncology face unique challenges because treatment with radiation, surgery and chemotherapy may 
adversely affects growth and development and may cause serious long term medical and psychosocial  effect.54,59,65 
Molecular cytogenetics, Immunohistochemistry and histochemical stains play a major role in determining the exact 
underlying pathology of various paediatric cancers. 
 
 
This study is undertaken in view of evaluating the actual incidence of paediatrics neoplasms in semi urban area like 
Thanjavur with particular attention to the age, sex, site and histopathology of cancers. In addition, the recent literatures, 
journals and research publications regarding paediatric cancers are also immensely reviewed.   
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AIM OF STUDY 
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1. To evaluate the incidence and prevalence as well as trend of paediatric neoplasms in semi urban area. 
2. To evaluate the clinical features, symptoms and signs associated with childhood malignancies. 
3. To study paediatric tumours under three broad categories i.e  haematological  malignancies, soft tissue sarcomas and 
CNS tumours. 
4. To evaluate the initial role of histochemical stains in diagnosis of haematological neoplasms. 
5. To study the value of immunohistochemistry in final diagnosis of paediatric tumours.  
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MATERIALS AND   METHODS 
 
Children and adolescence presented with malignant neoplasms referred from Raja Mirasudhar Govt. Hospitals 
(RMH), Thanjavur which is affiliated to Thanjavur Medical College (TMC) during 2003 – 2005 where included in this 
study. A thorough clinical evaluation routine haematological investigations, ultra sonogram and CT scan (in proportion of 
cases) were done in each case. 
A detailed history with particular attention to consanguinity, socio economic status, nutrition, radiation, exposure to 
pesticides, parental occupation and also similar neoplasms in other family members were also recorded. 
 
A- HAEMATALOGICAL & LYMPHO RETICULATOR SYSTEM 
The routine haematological evaluation when reveals malignancies such as acute leukemia, the slides were stained 
routinely with Leishman and Giemsa stains (Appendix I & II ) and further subjected to histochemical evaluation with 
special stain such as periodic-acid-schiff and sudan black B (appendix III) 
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Lymph node specimen with initially suspected lymphoma are with initial cytomorphological diagnosis lymphoma 
were fixed in toto in buffered neutral formation and processed routinely. 3-5 micrometer sections were cut and stained with 
haematoxylin and eosin (appendix IV) Reticulin and CD makers (in proportion of cases) were also applied in doubtful cases 
for final conformation (appendix V, VI). 
 
  
B - SOFT TISSUE AND BRAIN CANCERS 
 Like lymph node, the soft tissue cancer and brain neoplasms are also examined carefully from the reception itself 
and larger specimens were sliced at 1cm interval without distorting the gross pathology and fixed in neutral  buffered 
formalin and processed routinely.  3 to 5 sections were cut and stain with routine H and E. Immunohistochemistry with 
GFAP marker were also performed in doubtful CNS Neoplasms. 
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REVIEW OF LITERATURE 
 
The biologic nature of tumors of childhood is clinically, histopathologically, and biologically distinct from that of 
adult-onset malignancies.  Childhood cancers tend to have short latency periods, are often rapidly growing and aggressively 
invasive, are rarely associated with exposure to carcinogens implicated in adult-onset cancers, and are generally more 
responsive to standard modalities of treatment, in particular chemotherapy. 
 14
 
Malignant tumors between the ages of 1 and 15 years are distinctly uncommon, but cancer remains the leading cause 
of death from disease in this age group.  Unlike adults, in whom most cancers are of Epithelial origin (e.g., carcinomas of 
the lung, breast, and gastrointestinal tract) most malignant tumors in children arise from hematopoietic, nervous, and soft 
tissues.  Another feature that distinguishes childhood tumors from those of adults is the fact that many of the former are part 
of developmental complexes.  Examples include are part of developmental complexes.  Examples include Wilms tumor 
associated with aniridia, genitourinary malformations, and mental retardation (WAGR complex) hemi hypertrophy of the 
body26,58,69 hepatoblastoma, and adrenal carcinoma and tuberous sclerosis in blastoma, and adrenal carcinoma, and tuberous 
sclerosis in association with renal tumors and rhabdomyomas of the obviously developmental tumours that have evolved in 
utero.  In addition, abnormally developed organs, persistent organ primordial, and displaced organ rests are all vulnerable to 
neoplastic transformation. 
 
HAEMATOLOGICAL AND LYMPHORETICULAR MALIGNANCY 
 
LEUKEMIA 
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Leukemia is the most common form of cancer in children approximately 2500 new cases of childhood leukemia are 
diagnosed each year in the United States. ALL and AML are diagnosed in 75 % and 20 % of the cases, respectively, and 
chronic myeloid leukemia in fewer than 5 %. The well – established peak incidence of childhood leukemia at age 4 years is 
due to ALL.43, 53 
 
The FAB system divides ALL in to three morphologic subtypes [L1, L2, and L3] L1 lymphoblasts, the most common 
FAB type in children, have scantly cytoplasm and inconspicuous nucleoli.  Blasts in the L2 category account for 10% of 
cases, they are larger and more Pleomorphic in size, with abundant cytoplasm and prominent nucleoli, and they may be 
difficult to distinguish by morphology alone from FAB subtype M0 AML.  L3 is the rarest subtype (1% to 2%) of ALL, and 
these blasts have very basophilic vacuolated cytoplasm.  These L3 blasts have the same immunophenotype as well as 
karyotype and molecular genetic abnormalities as the tumor cells in small no cleaved or Burkitt lymphomas [L3] 
The FAB classification recognizes eight subtypes of AML (M0 to M10)   
 -Acute myeloid leukemia minimally differentiated  
- Acute myeloid leukemia without maturation 
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- Acute myeloid leukemia with maturation. 
- Acute myelomonocytic leukemia. 
- Acute monoblastic and monocytic leukemia. 
- Acute Erythroid leukemia. 
- Acute megakaryoblastic leukemia. 
- Acute Basophilic leukemia. 
-Acute pan myelosis with myelofibrosis. 
- Myeloid sarcoma. 
 
CYTOCHEMISTRY: 
Myeloperoxidase (MPO): 
Myeloperoxidase activity is specific for myeloid differentiation. Myeloperoxidase activity is stable for approximately 
four weeks in unstain smears kept at cool room temperature. Myeloperoxidase in myeloblast is granular and often 
concentrated in the golgi zone. Monoblast may be negative or positive with scattered fine granules. Lymphoblasts and 
megakryoblasts are MPO negative. 
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Sudan Black B (SBB):  
 SBB reactivity is similar to MPO in Myeloblast and monoblast and is stable for months in unstained slides.Its 
specificity for the myeloid lineage is less than MPO positive cells stain more intensely than MPO. Lymphoblast are usually 
negative. Black granules in Neutrophils and myeloblasts. 
 
 
LYMPHOMA 
 
 The lymphomas are the third most common childhood malignancy and account for approximately 10% of cancers in 
children.  Approximately two-thirds of the lymphomas diagnosed in children are Non-Hodgkin’s lymphoma  
(NHL) 30,31,33,41,51,56 and the remainders are Hodgkin;s disease.4,11,16,22,61  The spectrum of NHL seen in paediatric patients 
differs significantly from that seen in adults. 
 
HODGKIN’S LYMPHOMA 
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Hodgkin’s disease is a lymphoreticular malignancy characterize by a progressive painless enlargement of 
lymphnodes and define by specific histopathological features include a partial or total replacement of nodal architecture by 
an inflammatory cellular background containing Reed- Sternberg (RS) cells and their variants. 
 
Childhood Hodgkin’s disease is a lymphoma displays characteristic epidemiological, clinical and pathological 
features according to various geographic areas, particularly according to the socio economic level of a country. High male 
to female ratio, younger age at presentation, high proportion of advanced stages and presence of constitutional symptoms, 
predominance of mixed cellularity type of HD disease. 
 
WHO histological classification of Hodgkin’s Lymphoma 
Nodular Lymphocyte predominant Hodgkin’s Lymphoma       NLPHL 
Classical Hodgkin’s Lymphoma              CHL 
Nodular Sclerosis Classical Hodgkin’s Lymphoma         NSHL 
Mixed cellularity Classical Hodgkin’s Lymphoma         MCHL 
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Lymphocyte- Rich Classical Hodgkin’s Lymphoma               LRCHL 
Lymphocyte-Depleted Classical Hodgkin’s Lymphoma            LDHL  
 
NON-HODGKIN’S LYMPHOMA 
 Non-Hodgkin’s lymphoma (NHL) results from malignant cloned proliferation of lymphocytes of T-B- or 
intermediate cell origin. 
 
 
Clinical manifestations: 
 Lymphoblastic NHL often present as an intrathoracic tumour, usually a mediastinal mass and is associated with 
dyspnoea, chest pain, dysphagia, pleural effusion and superior vena cava syndrome. Cervical and axillary lymph adenopathy 
is present in up to 80 % of the patient at diagnosis. Primary involvement of bone, bone marrow, testis or skin is not 
uncommon. 29, 37, 74, 75  
The central nervous system (CNS) may also be involved.  
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 SNCCC present as an abdominal tumour in 80 % of united state cases in patient with abdominal pain or distention, 
bowel obstruction, change in bowel habits, intestinal bleeding or rarely intestinal perforation. Other sites include CNS, bone 
marrow and peripheral lymph nodes.  
LCL occurs in many sites including abdomen and Mediastinum. Extra medullary sites include skin, bone, soft tissue. 
CNS involvement is rare in contrast to SNCCL and lymphoblastic NHL. 
 
Morphology: 
Morphology of large cell lymphoma: 
Diffuse lymphoma composed of large transformed B cells. Four morphological variants are recognized in WHO 
classification: - centroblastic, immunoblastic, T cell rich/ histocytic rich and anaplastic lymphoma. 
Histopathological Features: 
   DCBCL usually have a predominance of large transformed lympoid cells with vesicular chromatin. 
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 Those of centroblastic type where the neoplastic cells resembles larger transformed follicular center cells have nuclei 
usually larger than histocytic nucleai with round to oval but sometimes more irregular nucleai contours, dispersed 
chromatin, one to more moderatelly prominent  nucleoli, cytoplasm is generally scanty and amphophilic to basophilic. 
 
Immunoblastic type:  
Majority of the cell 90 % are immunoblasts with single centrally located nucleus an appreciable amount of basophilic 
cytoplasm less than 5% of the population is represented by centroblast. 
 
T- Cell / histiocyte rich:- 
 In this variant the majority of the cells are non-neoblastic T cells with or without histiocytes and fewer than 10% 
large neoblastic B cells are present. 
 
Anaplastic large B cell lymphoma: 
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 Characterized by large round, oval or polygonal cells with bizarre pleomorphic nuclei which may resemble Reed – 
Sternberg cells.31, 33, 34  
 
 
Anaplastic large T cell lymphoma: 
  Characterize by Broad morphologic spectrum however all cases contain a variable proportion of cells with eccentric, 
horse shoe or kidney shaped nuclei. Often with an eosinophilic region near the nucleus. Some of the cell may appear to 
contain cytoplasmic inclusions, they are the invaginations of the nuclear membrane. Cells with there features have been 
referred to as dough nut cells. ALCL have more adbundant cytoplasm. Cytoplasm may appear clear, basophilic or 
eosinophilic. Multiple nuclei with wreath like pattern may present. Severe cytomorphological variants have been 
recognized. These include 1.common 2.Lympho histrocytic 3. Small cell variants. 
 
Morphological features of Burkitt’s lymphoma: 
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Medium sized cells show diffuse monotonous pattern of infiltration. The cells exhibit squared borders of retracted 
cytoplasm and may appear cohesive. The nuclei round with clumped chromatin and contain lipid vacuoles. 
 
 A “starry sky” pattern is usually present imparted by numerous benign macrophages that have ingested apoptotic 
tumour cells. 
Other variants are BL with plasmacytoid differentiation, A typical Burkitt or Burkitt’s like. 
 
 
Lymphoblastic lymphoma: 
Lymphnode show complete effacement with involvement of the capsule. A starry sky effect may present. 
 
Partial involvement present in a para cortical location with sparing of germinal centre may occur. In some cases, the 
predominant population of blast has convoluted nuclei. Mitotic figure may be numerous. A small number of patients with 
TLBL, eosinophilia and myeloid hyperplasia has been observed. 
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Immunophenotyping: 
Lymphoblastic lymphoma:  
Tdt posstive. Variable expression of CDla, CD2, CD3, CD4, CD5, CD7, and CD8. Among these CD7 and 
cytoplasmic CD3 are most often positive. 
 
Burkitt Lymphoma:  
Tumour cells express membrane IgM with light chain restriction. B cell associated antigen CD19, CD20, CD22, 
CD10, BCL-6 cell negative for CD5, CD23, Tdt, BCL2 is not expressed. 
 
 
 
Large cell Lymphoma:  
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Diffuse large B cell lymphoma express various Pan- B markers such as CD19, 20, 22 and CD79 and for cytoplasmic 
immunoglobulin can be demonstrated in 50 – 75 % of cases. 
Anaplastic large B cell expresses CD30: 
Some cases expresses CD5 (10 %) or CD10 (25 -50%) CD5 and DLBCL are negative for cyclin D1 expression. 
Anaplastic large T cell lymphoma: 
 Positive for CD30 on the cell membrane and in the golgi region strongest reaction in large cells, smaller cells a only 
weakly positive or negative for CD30. 
 ALK staining may be cytoplasmic and nuclear or it may be restricted either to nucleus or to the cytoplasm.50, 51, 56 
 
SOFT TISSUE AND BONE TUMOURS 
Neuroblastoma and Ganglioneuroblastoma 
About 85% of all neuroblastomas and ganglioneuromblastomas occur in the first 4 years of life, with a median age of 
about 21 months there are no sex-related differences in incidence rates.12, 21, 35, 68 While almost 70% of cases arise in the 
adrenal gland or intra-abdominal sympathetic chain, at least 20% arise in the thorax (including the thymus).  
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 The tumors may appear as a discrete spheroidal mass or a large bulky tumor with a multinodular surface.  There may 
be invasion of adjacent organs or tissues. 
On cross-section: 
Neuroblastomas are often coarsely nodular with areas of hemorrhage and necrosis. The gross appearance can 
simulate a hematoma with cystic degeneration.  Calcification within the tumor may appear as chalky white or yellowish 
punctate areas. Specimen radiography may demonstrate this to much better advantage.  Cystic neuroblastomas have been 
reported which simulate a hematoma or adrenal cyst.  Ganglio-neuroblastomas show an increased level of differentiation 
and this may be reflected on gross examination as a neoplasm with a more homogeneous appearance on cross-section. 
 
Microscopically: 
Neuroblastoma is the prototypic example of the “small blue cell” tumor of childhood, and usually has an ill-defined 
lobular or nesting pattern with thin fibrovascular septa.  Markedly nested (“organoid”) cases are said to carry an improved 
prognosis. There is often a variable amount of pale, fibrillary material between cells, representing neuritic cell processes.  
This neurofibrillary matrix, which has been likened to neuropil of the central nervous system, may form the center of 
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rosettes or broad mats with irregular contour, rarely the rosettes have a rhythmic or palisading configuration.  In 
undifferentiated neuroblastoma the neurofibrillary matrix may be absent altogether, making diagnosis more difficult.  
Nuclear chromatin usually is finely dispersed in small clumps, imparting a speckled or “salt and pepper” appearance, 
nucleoli generally are inconspicuous although they may become prominent with ganglion cell differentiation.  Anaplastic 
neuroblastoma has also been described but its significance remains uncertain.  Other unusual histopathologic features have 
been reported such as a sclerosing pattern, spindle-shaped neuroblasts, stromal hyalinization, and dense lymphoplasmacytic 
infiltration, some of which may be related to the phenomenon of regression. 
 
Renal tumors in children 
Primary renal neoplasms are uncommon in children fewer than 500 new cases occur in the U.S.A. annually.26, 58, 69 
However, they constitute the fifth most common group of pediatric cancers and are the second most frequent abdominal 
malignancy of children. 
 
 28
The most common tumor in this group is Wilms tumor (nephroblastoma).  Important because of their poor response 
to therapy and consequent morbidity and mortality are clear cell sarcoma and rhabdoid tumor.  In children younger than 
three months, mesoblastic nephroma is the most common renal neoplasm and usually has a favorable prognosis.  A final 
rare tumor, the ossifying renal tumor of infancy.  Tumors such as renal cell carcinoma, lymphoma, sarcomas, 
neuroendocrine tumors and angiomyolipoma, which usually are found in adult kidneys, occur rarely in children but do not 
in most instances differ pathologically in this age group from their adult counterparts, although there is a rare oncocytoid 
form of renal cell carcinoma apparently only seen after treatment for neuroblastoma.  Much of what we know today about 
the pathology of renal neopasia in childhood is the result of the work of the National Wilms’ Tumor Study (NWTS) and its 
Pathology Center under the direction of Dr.Bruce Beckwith. 
 
Wilms’ tumor 
 Wilms’ tumors comprise more than 80% of renal tumors of childhood.26,58,59  Most often, they are found in children 
2-4 years old (median ages for males and females, respectively, are 37 and 43 months) they are relatively uncommon in the 
first 6 months of life and in children older than 6 years.  Wilms’ tumors are rare in the neonatal period.  There is a slight 
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preponderance of females.  The tumors are bilateral in 4.4% of cases and patients with bilateral tumors average more than a 
year younger than patients with unilateral tumors.  Associations with congenital anomalies including cryptorchidism, 
hypospadias, other genital anomalies, hemihypertrophy, and aniridia are well recognized.  As many as 5% of patients with 
Beckwith-Weidemann syndrome develop Wilms tumors.  Patients with the Drash syndrome also have an increased risk of 
developing Wilms tumors.  A variety of other malformations are less frequently associated with Wilms tumors.  
Uncommonly, Wilms tumors have a familial association. 
 
Macroscopic Appearances 
 Wilms tumors are usually large masses more than 5 cm in diameter and a third or more are larger than 10cm.  Often 
they weigh more than 500g.  The cut surfaces are typically solid, soft and grayish or pinkish resembling brain tissue.  Foci 
of hemorrhage and necrosis are often present and cysts are common.  Rarely, the tumors are extensively cystic.  The tumors 
usually are enclosed by a prominent pseudo-capsule composed of compressed renal and perirenal tissues this, gives an 
appearance of circumscription and even true encapsulation.  Polypoid growth in the renal pelvic cavity, mimicking sarcoma 
botryoides. 
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Histologic Appearances 
 Wilms tumors are typically composed of variable mixtures of blastema, epithelium and stroma, although in some 
tumors only two components, occasionally only one is present.  Blastema consists of sheets of randomly arranged, densely 
packed small cells with darkly staining nuclei, frequent mitotic figures, and inconspicuous cytoplasm, resembling to some 
extent, other “small blue cell tumors” of childhood.  Blastema is commonly arranged in three patterns – serpentine, nodular, 
and diffuse.  Serpentine and nodular are most common and diagnostically helpful.  They consist of anastomosing 
serpiginous or spheroidal aggregates of blastema, sharply circumscribed from the surrounding stromal elements. 
MALIGNANT TUMORS OF BONE 
 Annual incidence of malignant tumors in United States is approximately 7 cases per million in which children 
younger than 15 years of age, with slightly lower incidence in black children. Osteosarcoma hosorcem is the primary 
malignant tumor of bone in children younger than 10 years of age followed by Ewings sarcome of bone.1, 3,8,46 
Ostesarcoma can be defined simply as a malignant tumor in which osteoid or bony matrix is produced by the tumor 
cells.  Osteosarcomas can be subdivided broadly into two groups, the majority occur within the bone but a small minority 
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occur on the surface.  These two broad categories can be further subdivided depending on the clinical, roentgenographic and 
histologic features. 
Classification of osteosarcoma 
Osteosarcomas within bone 
Conventional osteosarcoma 
• Osteoblastic 
• Chondroblastic 
• Fibroblastic 
Small cell osteosarcoma 
Telangiectatic osteosarcoma 
Low-grade central osteosarcoma 
Osteosarcoma in Paget’s desease 
Post-irradiation osteosarcoma 
Osteosarcoma in other benign precursors 
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Surface osteosarcomas 
Parosteal osteosarcoma 
Periosteal osteosarcoma 
High-grade surface osteosarcoma 
 
The clinical symptoms are quite non-specific.  Patients complain of pain or swelling or both of variable duration, 
ranging from days to months.  Pathologic fracture may be the initial symptom.  The roentgenographic features of 
osteosarcoma are quite variable.  The tumor usually gives rise to a large area of destruction of bone with extension into soft 
tissue.  The amount of mineral present in the lesion varies and correlates somewhat with the type of osteosarcoma.  As the 
tumor destroys the cortex, it lifts up the periosteum.  This results in reactive new bone formation at the junction between the 
elevated periosteum and the underlying cortex.  This is referred to as Codman’s triangle.  Rarely, an osteosarcoma is small 
and extremely well circumscribed, suggesting a benign lesion. 
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The gross appearance of osteosarcoma also is quite variable.  Most have the fish-flesh appearance associated with 
sarcomas.16, 17 Some are heavily mineralized and hence extremely hard.  Some have large areas of obvious blue cartilage. 
 
Microscopically, most osteosarcomas are highly malignant tumors their spindle cells have nuclei with marked 
pleomorphism.  Conventional osteosarcoma can be further subdivided into osteoblastic, chondroblastic and fibroblastic 
varieties, depending on the predominant matrix.  
Approxiamtely half of all osteosarcomas can be called “osteoblastic”.  Characteristically, the matrix is produced as a 
fine network between individual tumor cells.  The matrix may be in the form of unmineralized osteoid or may show 
mineralized trabeculae.  About 25% of osteosarcomas show predominantly cartilaginous differentiation.  The cartilage is in 
the form of lobules and the cells within lacunae show marked anaplasia.  Osteoid matrix may be seen between the spindle 
cells or in the center of chondroid lobules.  In a small biopsy specimen, osteoid may not be seen between spindle cells. 
 
Approximately 25% of osteosarcomas have a pre-dominantly spindle cell pattern and minimal amounts of matrix 
production.  These are called “fibroblastic osteosarcomas”. 
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EWINGS SARCOMA AND PNET 
Ewings sarcoma and PNET are rare sarcomas of bone & soft tissues described in 1921 by Dr.James Ewing.5, 67 Both 
Ewings sarcoma & PNET share in over 90% of the cases balanced translocation T (11, 22) and they are almost now 
universally referred as ends of a common histologic spectrum known as “Ewings family of tumor (EFTS). 
 
In bone, Ewing’s sarcoma is a rare primary neoplasm of bone comprising approximately 6% of all malignant bone 
tumors in the Mayo Clinic files.5, 67 The tumor is slightly more prevalent in males than in females.  The majority of patients 
(more than half of the Mayo Clinic patients) are in the second decade of life.  It is unusual to see Ewing’s tumor in patients 
younger than 5 years (only 2% of Mayo Clinic patients).  Similarly, just over 3% of the patients were close to age 50 years.  
Any portion of the skeleton may be involved, but more than half of the tumors involve the long bones, usually the diaphysis. 
 
Typical Ewing’s sarcoma is composed of small round uniform cells.  The nuclei are round and the nucleoli are 
inconspicuous.  The nuclei have a rather smoky appearance.  Mitotic activity usually is not prominent in typical Ewing’s 
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sarcoma.  Special stains and electron microscopy usually demonstrate cytoplasmic glycogen in up to 70% of Ewing’s 
Sarcomas. 
 
 Askin et al described a small cell tumor of the thoracopulmonay region in childhood.65, 67 They distinguished these 
lesions from Ewing’s sarcoma because of unusual histologic features and suggested that they are neurally derived.  In their 
series, the prognosis was worse than for Ewing’s sarcoma. Contesso et al, compared Askin’s tumor with classic Ewing’s 
sarcoma.65, 67 situated in other locations.  They found no significant difference in the immunohistochemical profile of 
Askin’s tumor and classic Ewing’s sarcoma.  The characteristic chromosomal translocation (11, 22) present in Ewing’s 
sarcoma has been described in Askin’s tumor, peripheral neuroectodermal tumor and esthesioneuroblastoma but not in 
primitive neuroectodermal tumor of the brain.  The concept that Ewing’s sarcoma may be a form of a neuroectodermal 
tumor has been supported by several electron microscopic tissue culture and immuno histochemical studies 
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Rhabdomyosarcoma 
 Soft tissue sarcoma occur with an annual incidence of 8.4 cases/million children younger than 15 years of age 
incidence in black children in 50% of that white children.  Rhabdomyosarcoma accounts for more than half of the soft tissue 
sarcomas. The prognosis mostly slightly correlates with extent of disease at diagnosis, primary tumor site and type of 
treatment. 
 
Rhabdomyosarcoma are malignant neoplasms which show morphologic, immunohistochemical, ultrastructural or 
molecular genetic evidence of primary skeletal muscle differentiation usually in the absence of any other pattern of 
differentiation.  
It accounts for around 60% of childhood cases,45,46,47 in its classical form consists of small round or spindle shaped 
undifferentiated (basophilic) cells, admixed with variable numbers of round strap or tadpole-shaped eosinophilic 
rhabdomyoblasts in a myxoid stroma.  Cytoplasmic cross-striations are present in no more than 20-30% of cases but even in 
tumors with almost no discernible rhabdomyoblasts, desmin or muscle actin immunostains are positive in more than 95% of 
cases and this is therefore the most reliable means of making the diagnosis in the routine setting.  Additionally, well 
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characterized antibodies to the protein products of specific myogenic nuclear transcription factors, MyoD1 and myogenin 
(myf4) are proving to be extremely useful.  Occasional cases (more often of embryonal type than alveolar) show a 
remarkable degree of cytoplasmic differentiation becoming much more obviously rhabdomyoblastic after chemotherapy. 
 
OTHER SOFT TISSUE SARCOMAS 
  The nonrhabdomyosarcomas soft tissue sarcoma (NRSTS) constitutes a heterogeneous group of tumors that account 
for 3 % of all childhood malignancies.16, 17, 70, 71 Because they are relatively rare in children. Much of the information about 
their natural history and treatment has been derived from the studies of adult patients. 
 
 In children the median age of diagnosis is 12 years of age and male predominate (male:female ratio 2.3 : 1). Most 
common histologic types are synovialsarcoma (42%), fibrosarcoma (13%), Malignant fibrous histiocytoma(12%) and 
neurogenic tumors(10%). These tumors  commonly arise in the trunk or lower extremities. Tumor size, stage, invasiveness 
and histologic grade correlate with survival.  
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RETINOBLASTOMA 
 Retinoblastoma is the most common intraocular tumor in childhood and the most common tumor of the retina but it 
is a rare malignant tumor with a prevalence of about 1/23000 live births in England 1/16000 in Holland and 1/20000 in 
Japan.3,25,79  Retinoblastoma has changed from an almost uniformly fatal disease to one in which 95% of patients are cured.  
The genetic cause of retinoblastoma was found to be the loss of both alleles of a normal tumor suppressor gene (the Rb 
gene) on the long arm of chromosome 13.  This gene, classified as a recessive oncogene or tumor-suppressor gene has been 
closed.  Researchers then discovered that mutations of the Rb gene play a role in the development of a wide variety of 
cancers in addition to retinoblastoma.  
 
HEPATOBLASTOMA 
Hepatoblastoma accounts for only 0.2-5.8% of malignancies in childhood but for 25-45% of all primary hepatic 
tumors and for about 50% of those that are malignant.  The vast majority 83-92% occur in patients under 5 years of age, and 
66% are seen in the first 2 years of life.8,19,32 Rarely, the tumor may be present at birth.  Males are twice as commonly 
affected as females but the frequency becomes nearly equal in older children.  A third of patients with hepatoblastoma have 
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some form of congenital anomaly syndrome or other childhood tumor.  These include hemihypertrophy, cleft palate, talipes, 
cardiac and renal malformations, diaphragmatic hernia, Beckwith Wiedemann and Down’s syndromes, and nephroblastoma.  
Cytogenetic abnormalities are common especially trisomies of chromosomes 2 and 20.  Hepatoblastoma is now recognized 
as part of the familial adenomatous polyposis syndrome. Anecdotal case reports have attempted to link hepatoblastoma to 
maternal oral contraceptive use but this has been refuted by a large case-control study which also excluded alcohol smoking 
and HBV infection but pointed to the possible role of parental occupational exposure to metals, solvents and pigments. 
 
Microscopically 
 Most hepatoblastomas fall into the mixed epithelial and mesenchymal categories if sufficient tissue is available for 
examination.  Less common are an anaplastic small cell and a macrotrabecular variant.  Other rare types are teratoid, 
mucoid and rhabdoid.  The most recent classification recognizes six subtypes of hepatoblastoma epithelial (fetal, embryonal 
and fetal, macrotrabecular, small cell) and mixed epithelial-mesenchymal (with or without teratoid features).  Teratoid 
hepatoblastomas may contain squamous epithelium, neural and melanocytic cells and endocrine components which are not 
found in developing or normal adult livers.  The majority of hepatoblastomas consist of liver epithelial cells in various 
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stages of development and a mesenchymal component that is usually spindle-celled or osteoid.  The epithelial component 
may be of several types, the presence of two or more being required for the diagnosis.  Embryonal-type cells are smaller, 
enlongated or fusiform and darkly staining.  They have hyperchromatic nuclei and little cytoplasm.  They may aggregate 
into rosette-like clusters or appear as cords or ribbons but seldom as tubules.  Fetal-type cells are polygonal and relatively 
large, almost the size of normal liver cells.  They have round to oval nuclei and single nucleoli the cytoplasm may be 
granular or clear, depending on the amount of glycogen and fat.  These cells are generally organized into irregular plates 
with bile canaliculi and sinusoids.  Extramedullary hematopoiesis is commonly seen.  These two cell types are invariably 
present and occur in varying proportions, often intimately mingled. Anaplastic small cells grow in sheets and are 
indistinguishable from neuroblastoma and other primitive tumors of childhood.  Some tumors have a mucoid stroma.  The 
macrotrabecular component resembles adult liver cell carcinoma.  Intestinal-type glandular elements may also be seen. The 
mesenchymal component characteristically consists of osteoid and undifferentiated spindle-celled mesenchyme.  Other 
elements-namely cartilage, striated muscle and neural tissue – are rarely seen.  All the components of hepatoblastoma 
probably derive from a stem cell precursor.   
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IMMUNOHISTOCHEMICAL STUDIES  
They have demonstrated AFP, hCG, CEA, epithelial membrane antigen (EMA), hepatic cytokeratins (8 and 18) and 
biliary cytokeratins (7 and 19), α1-antitrypsin, ferritin, S-100 protein chromogranin A and neuron-specific enolase in a 
varying proportion of cases.32, 46  AFP is readily demonstrable in fetal and embryonal types of cell, hCG in giant cells and 
vimentin in anaplastic cells; cells embedded in osteoid express cytokeratins.  Ultrastructural studies have shown simple 
cytoplasmic organelles, few mitochondria, bile canaliculi with microvilli, dilated endoplasmic reticulum and fibrillar or 
amorphous inclusions.   
 
Surgical resection is the best treatment, preceded by accurate staging and chemo/radiotherapy. Results have 
improved in recent years 90% of hepatoblastomas can be made respectable and the cumulative probability of survival in 
patients treated with intent to cure is about 2 in 3.  Poor prognostic indicators are age under 1 year large tumor size, 
involvement of vital structures and predominance of small anaplastic cells or macrotrabeculae. Small cell lesions are 
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associated with a uniformly fatal outcome and the macrotrabecular type is resistant to chemotherapy.  The outcome is best 
in those cases in which the pre-treatment serum AFP level falls by at least two logs. 
 
 
ADENOCARCINOMA OF THE COLON AND RECTUM 
 Colorectal carcinoma rarely presents in the pediatric population.  There is a male predominance, as compared with a 
female predominance in adults.  Even in patients with predisposing condition, such as familial adenomatous polyposis and 
Peutz-Jeghers syndrome, cancer usually does not present until adulthood, although screening should begin during childhood 
or adolescence.  Presenting symptoms include bloody stools or malena, abdominal pain, weight loss, and changes in bowel 
pattern.  Signs are often vague, often resulting in a delay in diagnosis and advanced disease.  The histologic subtype differs 
from that seen in adults, with the majority of pediatric tumors being mucinous. Treatment consists of surgical resection 
when possible with chemotherapy for unresectable tumors.  Irradiation is useful in the treatment of rectal carcinomas. 
PAEDIATRIC BRAIN TUMOURS 
Epidemiology: 
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 Primary CNS tumours are a hetrogenous group of disease. The central Nervous system tumours comprises 19 % of 
these astrocytoma is more common followed by medulloblastoma and ependymoma. 
 
 Paediatric brain tumours are mainly infratentorial, which is different from what is seen in adults. 59 % of the brain 
tumours in children are infratentorial while 41 % are supratentorial. This applies to all ages below 15 years. However the 
ratio is differs in the first year of life. 
 Higher incidence of CNS tumours in infants and young children up to 7 yrs of age compared with the older children 
and adolescence. 
 
Pathogenesis: 
World Health Organization (WHO) classification of tumours of CNS and meninges include five categories such as 
juvenile pilocytic astrocytoma, medulloblastoma / primitive neuroectodermal tumour (PNET), diffuse astrocytoma, 
ependymoma and  craniopharyngioma constitute 80% of all paediatric brain tumours. 
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 There are age related differences in primary location of the tumour. Within the I year of life supratentorial tumour 
predominate and include most commonly choroid plexus complex tumours and teratomas. From 1-10 yrs of age, 
infratentorial tumours predominate owing to the high incidence of juvenile pilocytric astrocytoma and medulloblastoma. 
 
 After 10 yrs of age, once again, supratentorial tumours predominate, with the diffuse astrocytomas. Most common 
tumours of the optic pathway and    hypothalamous, the brain sterm and pineal-midbrain region occur with a greater 
incidence in children and adolescence than in adults. 
 There is little understanding of the etiology of the brain tumours. A male predominance is noted in the incidence of 
medullablastoma and ependymoma familial and hereditary syndromes associated with increased incidence of brain tumours 
account for approximately 5 % of the cases. 
 
 Cranial exposures to ionizing radiation is also associated with an increase incidence of brain tumours. Sporadic 
reports of brain tumours within females without evidence of a heritable syndrome. The molecular events associated with the 
tumorigenesis of paediatric brain tumours are not known. 
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Classification: 
 Brain tumours are classified according to histology but tumour location and extent of spread are important factors 
that affect the treatment and prognosis. 
Immunohistochemical analysis cytogenetic and molecular genetic findings and measures of mitotic activity are increasingly 
used in the tumors diagnosis and classification. 
The Classification of childhood brain tumours is based not only in histology but also on location. Tumours are 
classifiably categorized as infratentorial, sellar (or) suprasellar on cortical based.42,46 
 
Clinical Manifestations 
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   Clinical presentation of patients with brain tumours depends on the tumour location, tumour type and the age of the 
child.  Signs and symptoms are related to the tumor causing obstruction of cerebrospinal fluid (CSF) drainage paths leading 
to increased intracranial pressure (ICP) and /(or) causing local brain dysfunction. 
 
 Subtle changes in the personality Mentation and /or speech may proceed the classic sign and symptoms of the brain 
tumours. 
 
In young children the diagnosis of a brain tumour may be delayed because their symptoms are similar to those of 
more common illness such as gastro intestinal disorders. 
 Classic triad of Head ache, nausea and/or vomiting and papilloedema is associated with mid line (or) infratentorial 
tumours. 
 
Supratentorial tumours are more commonly associated with local disorders such as motor weakness sensory changes, 
speech disorders, seizures and reflex abnormalities. 
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MEDULLOBLASTOMA 
 
 This is a primitive tumour and is a type of the primitive neuro-ectodermal tumour group.  Medulloblastomas are 
usually solid arise from the cerebellar vermis and extend to fill the cavity of the 4th ventricle.  It is the most common solid 
tumour of the childhood.  20 to 30% of posterior fossa tumour in childhood are Medulloblastomas and the age incidence is 5 
to 8 yrs of age.  It is reported that they are more common is males.2,8,10,19,20,66 
 
Desmoblastic variant of Medulloblastoma Grade 4 
Medulloblastoma may contain excessive fibrous connective tissue lacking reticulun (or) reticulin free zones 
compared with reticulin rich nature of regions of high cellularity. 
 
Such tumours are designated desmoplastic medulloblastoma.  These neoplasms are more  laterally located in the 
cerebellum then other medulloblastomas often in young adult.  The assumption is that the desmoplastic reaction is the result 
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of a Fibrous connective tissue proliferation by the leptomeningeal cells in the arachnoid space as a result of local invasion 
by the medulloblastoma cells. 
 
ASTROCYTOMA 
 
Astrocytomas are the most common paediatric brain tumours and comprise a heterogenous group of tumours with 
numerous subtypes.42,46  Because some designations or subtypes emphasize grading (low, anaplastic, GBM) accounting for 
approximately 40% of the cases.  These tumours occurs through out the CNS.  Malignant astrocytomas are much less 
common on children and adolescents than in adult accounting for 7-10% of all childhood tumours among these groups. 
Anaplastic Astroaytoma WHO grade III is more   common than glioblastoma multiforme (WHO Grade IV). 
  
Anaplastic Astrocytoma 
The designation anaplastic emphasizes the grade of malignancy.  Mitoses are considered a feature of anaplastic 
astrocytoma.  Because the percentage of mitosis in low grade diffuse astrocytoma is so low.  Quantitative features that are 
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shared by high grade gliomas are an increased cellular density, increased nuclear pleomorphism and increased nuclear 
hyperchromatism.  
 
Histologically 
Lack of low of coagulation necrosis and of microvasuclar proliferation in an astrocytic glioma distinguishes 
anaplastic astrocytoma from glioblastoma.  But individual cells with pyknotic nuclei may be interspersed through out the 
anaplastic astrocytoma.  So histopathology of anaplastic astrosytoma demonstrate increased cellularity, cellular and nuclear 
atypia, presence of mitoses compared with low grade diffuse astrocytoma. 
 
Glioblastoma Multiforme: 
 It is considered a glioma that may be uniformly undifferentiated, but it contains focal astrocytoma .  Mostly low 
grade glioma may progress to glioblastoma overt time. Many of these progressions are associated with overtime, specific 
genetic alteration including a loss of genetic material in chromosome 10. 
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Denovo Glioblastoma appears to exist as well.  Although most glioblastomas are supratentorial they also occur in the 
brainstem and common in cerebellum. 
 
 
 
 
EPENDYMAL TUMOURS 
 
 Derived from the ependymal lining of the ventricular system.  Ependymoma (who grade II) is the most common of 
these neoplasm, occurring predominantly in childhood tumours. 
 
 Approximately 70% ependymomas in childhood occur in posterior fossa.  The mean age of the patient is 6 yr, with 
approximately 30% of cases occurring in children younger than 3 yrs of age. 
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Variants 
1. Ependymoma - low grade 
2. Clear cell ependymoma 
3. Tanycytic ependymoma 
4. Sub ependymoma 
5. Myxopapillary ependymoma 
6. Anaplastic ependymoma (or) Malignant ependymoma 
 
 
 
 
 
Anaplastic expendymoma – Grade 3 
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 These  are uncommon-Although these tumours are often found in the cerebrum (or) cerebellum of children and young 
adult. 
Key Diagnostic criteria for anaplasia include 
1. Increased cellularity 
2. Nuclear anaplasia 
3. Brisk Mitotic activity 
Vascular proliferation, whether intramural (or) glomeruloid and necrosis including pseudo pallisading necrosis may be seen.   
 
     PRIMITIVE NEUROECTODERMAL TUMOURS (PNET) 
PNET are the most common group of malignant CNS tumours of childhood, accounting for 20-25% of paediatric 
CNS tumours. 
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PNET  has structure and staining properties of the cerebellar medulloblastomas, composed of undifferentiated (or) 
poorly differentiated neuroepithelial cells, identified PNET with supratentorial compartment. PNET has occurred in patients 
with renal tumours and renal tube defects. 
 
 
PNET also occur in peripheral location.  Most of the tumour associated with t(11,22) q(24, q12) chromosomal 
translocation and they stain with MIC – 2.  The sites include those that arise from the neural crest derivatives, gonads, chest 
wall bone rare peripheral PNET above in the craniospinal vault.  
 
Markers of Neuronal differentiation such as synaptophysin and protein gene product aid in the identification of 
PNET.  
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OBSERVATION AND RESULTS 
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This study covered a total of 132 paediatric cancers in which, 63 were hematological malignancies, 49 were soft 
tissue cancers and 21 were CNS Neoplasms. 
 In 63 Hematological cancers observed, 42 were males (66.67%) with age ranging from 2 - 15 yrs (mean age 8.2 yrs)  
and 21 were females (33.33%) with age ranging from 2 - 14 yrs ( mean age 8.6 yrs) 
Table No .1: shows total number of hematological malignancies observed during the period Jan - 2003 to December - 2005. 
The average incidence is 44.49% 
Table No - 1 
 
S.NO PERIOD TOTAL 
HEMATOLOGICAL 
CANCERS 
PAEDIATRIC 
CANCERS 
PERCENTAGE 
1 Jan 2003 – June 2003 
 
96 15 15.63% 
2 July 2003 – Dec 2003 
 
120 13 10.83% 
3 Jan 2004 – June 2004 
 
124 20 16.13% 
4 July 2004 – Dec 2004 
 
152 21 13.82% 
5 Jan 2005 – June 2005 167 33 19.76% 
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6 July 2005 – Dec 2005 
 
234 30 12.82% 
 
   
 
When  the  children  are   divided   in to   six    groups   (i.e ≤ 2yrs, 2 - 4 yrs,   
5 -6 yrs, 7 - 8 yrs, 9 -  10 yrs and >10 yrs) there was increased incidence of haemotological malignancies in the age group of 
more than 10 yrs, followed by 3 -4 yrs and 5 -6 yrs. Incidence of hematological/lymphoreticular malignancy is low at 
less than 2 yrs, as given in the following Table no– 2. 
 
Table no– 2 
 
 S.NO AGE MALE FEMALE TOTAL 
NO.OF 
CASES 
PERCENTAGE
1 ≤ 2 
 
4 - 4 6.6% 
2 3 – 4 
 
9 2 11 17.46% 
3 5 – 6 
 
7 4 11 17.46% 
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4 7 – 8 
 
2 5 7 11.11% 
5 9 – 10 
 
5 4 9 14.29% 
6 > 10 
 
15 6 21 33.33% 
 
Table - 2 also shows, incidence is high in male children (42 cases, - %) when compared with females (21 cases, 33.33 %). 
Most of the children with hematological/ lymphoreticular malignancies were from surrounding villages, with low 
socio economic status, presented with following clinical symptoms as given in the Table No 3 
 
 
 
 
Table No.3 
 
S.NO CLINICAL FEATURES NO.OF CASES PERCENTAGE 
1 Fever 
 
48 76.19 % 
2 Anemia 
 
52 82.54 % 
3 Upper Respiratory Tract 
Infection  
32 50.79 % 
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4 Jointpain(lower extremity) 15 23.79 % 
 
5 Bony tenderness 
 
2 3.17 % 
6 Gum Hypertrophy (Fig.1) 
 
41 1.59 % 
7 Chloromas 
 
- - 
8 Generalized 
lymphadenopathy 
58 92.06 % 
9 Spleenomegaly 
 
55 87.30 % 
10 Hepatomegaly 
 
38 60.32 % 
11 Bleeding manifestation 
 
25 39.68 % 
 
 
Most of the children presented with a triad of fever, anaemia and spleenomegaly as common presenting symptoms, 
and generalized lymphadenopathy is the commonest presenting symptom in children with lymphoreticular malignancies 
exhibiting firm, discrete, nontender enlargement of the lymphnodes. 
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 When paediatric hematological/lymphoreticular malignancies were divided, hematological cancers were observed in 
45 cases (71.43%) and lymphoid neoplasms in 18 cases (28.57%) 
 
 In 45 hematological cancers, 32 cases were acute lymphoblastic leukemia (Fig.2&Fig.3) [(ALL),(71.11%)] and 
[11cases,(24.44%)] were diagnosed as lymphoproliferative/lymphoma spill (Fig.6)  Lesions as given in the following Table 
No.4. Only 2 cases of Acute Myeloid leukemia (AML, 4.44%)(Fig.4&Fig.5)  was observed in this study. 
 
Table No.4 
 
 
SL.NO HEMATOLOGICAL MALIGNANCY NO.OF 
CASES 
PERCENTAGE
1 ALL 
 
32 71.11 % 
2 AML 
 
2 4.44 % 
3 JCMML 
 
- - 
4 CML 
 
- - 
5 LYMPHOPROLIFERATIVE/LYMPHOMA 11 24.44 % 
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SPILL 
 
Similarly, the Lymphoreticular malignancies were also divided, as shown in  
Table No. 5  
 
 
Table No-5 
 
SL.NO LYMPHORETICULAR 
MALIGNANCY 
NO.OF CASES PERCENTAGE 
1 HL 
 
3 16.67 % 
2 NHL 
 
  
 LARGECELL  LYMPHOMA 
 
10 55.56 % 
 BURKITTS LYMPHOMA 
 
2 11.11 % 
 LYMPHOBLASTIC 
LYMPHOMA 
1 5.56 % 
 OTHERS 
 
2 11.11 % 
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In 18 cases, 15 cases were NHL, in which large cell anaplastic Lymphoblastic type was commonly observed. Only 3 
cases of Hodgkin disease (Fig.7)  was observed in this study.  Cases were diagnosed initially as lymphoma, further 
confirmation with CD Marker- CD 30 for RS cell was also done. 
 
 
SOFT TISSUE NEOPLASMS (INCLUDING - ABDOMINAL AND BONE MALIGNANCIES) 
 
 In this prospective study, 48 soft tissue neoplasms were observed, in which 25 were male children (52. 08%) with age 
ranging from 1 month to 15 yrs (Mean age- 7.04 yrs) 23 were female (47. 92%) with age ranging from 1 month to 15 yrs 
(Mean age - 7.08 yrs). 
The Following Table No. 6 shows the total no. of soft tissue malignancies observed during the Period from JAN -
2003 To DEC - 2005. The average Incidence is 36. 36%. 
Table No-6 
 
SL.NO PERIOD TOTAL NO.OF 
SOFT TISSUE 
MALIGNANCY
PAEDIATRIC 
CASES 
PERCENTAGE
1 Jan 2003 to Dec 2003 
 
132 12 9.1 % 
2 Jan 2004 to Dec 2004 198 14 7.1 % 
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3 Jan 2005 to Dec 2005 282 22 7.8% 
 
 
Similarly as in hematological / lymphoreticular malignancies, when the children are divided into 6 groups as given in 
the following Table - 6, there was increased Incidence of paediatric soft tissue malignancies in the age group of 3-4 yrs, 
followed by more than 10 yrs and less than 2 yrs. 
 
The Table No-7 also shows that the incidence of soft tissue malignancies is common in males [25 cases (52.08%)] 
when compared with females [23 cases (47.92 %)]. 
 
 
 
 
 
Table No-7 
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SL.NO AGE MALE FEMALE TOTAL 
NO.OF 
CASES 
PERCENTAGE
1 ≤ 2 
 
4 4 8 16.67 % 
2 3 to 4 
 
11 5 16 33.33 % 
3 5 – 6 
 
- 4 4 8.33 % 
4 7 – 8 
 
- 2 2 4.17 % 
5 9 – 10 
 
4 - 4 8.33 % 
6 > 10 
 
6 8 14 29.17 % 
 
When the soft tissue neoplasms are categorised as given in the following  
Table No -7, Neuroblastoma (Fig.8&Fig.9) with Incidence of 16. 67% (8 cases) predominates over other malignancies, 
followed by ovarian tumors (Fig.10&Fig.11) and extraskeletal Ewing sarcoma (Fig.12) (5 cases, 10.42%). In this study 4 
cases of Hepatoblastoma, 4 cases of colorectal Adenocarcinoma and 4 cases of Retinoblostoma were also observed. 
Osteosarcoma, (Fig.13&Fig.14) Rhabdomyosarcoma, (Fig.15&Fig.16)  Nasopharyngeal and Laryngeal neoplasms were 
observed only in 3 cases respectively.  
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 Like wise, WILMS tumor, (Fig.17) once thought to be a common paediatric neoplasm was observed in only one 
case. 
Table No.8 also show, one interesting case of Melanoma - which was observed at 3 yrs Male child in the intra - oral 
region, Testicular tumor (Fig.18&Fig.19) at 3 yrs and Adrenocortical neoplasm at the age of 4 yrs.  
Table No – 8 
 
SL.NO SOFT TISSUE 
NEOPLASM 
NO.OF 
CASE 
PERCENTAGE AGE 
1 MALIGNANT MELANOMA 
 
1 2.08 % 3 yrs 
2 COLORECTAL MALIGNANT 
NEOPLASM 
4 8.33 % 10 – 13 
yrs 
3 NASOPHARYNGEAL 
&LARYNGEAL NEOPLASM 
3 6.25 % 13 – 15 
yrs 
4 OVARIAN TUMOUR 5 10.42 % 2 – 15 
yrs 
5 TESTICULAR TUMOUR 
 
1 2.08 % 3 yrs 
6 ADRENALCORTICAL 
NEOPLASM 
1 2.08 % 4 yrs 
7 RETINOBLASTOMA 
 
4 8.33 % 3 – 5 yrs 
8 NEUROBLASTOMA 
 
8 16.67 % 1 – 9 yrs 
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9 HEPATOBLASTOMA 4 8.33 % 1 month 
to 4 yrs 
10 EXTRASKELETAL EWING 
SARCOMA 
5 10.42 % 3 – 10 
yrs 
11 RHABDOMYO SARCOMA 3 6.25 % 1 – 15 
yrs 
12 LOW GRADE MPNST 2 4.17 % 12 – 15 
yrs 
13 BONE TUMOUR – OSTEO 
SARCOMA 
3 6.25 % 15 yrs 
14 WILMS TUMOUR 
 
1 2.08 % 4 yrs 
15 SALIVERY GLAND TUMOUR 
 
1 2.08 % 15 yrs 
16 OTHERS 
 
2 4.17 % - 
CNS NEOPLASMS 
 
In 21 CNS tumors observed in this study, 12 cancers were seen in Male children (57.14%) with age ranging from 1-
15 yrs (Mean age 8.33 yrs) and 9 were females (42.86%) with age ranging from 1-15 yrs (Mean age 8.77 yrs). 
The average incidence of Paediatric CNS - neoplasm is 15.90% as given in the following Table No-9, during the 
period from JAN - 2003 to DEC - 2005. 
 
Table No-9 
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When the children with 
CNS Neoplasms were also 
divided into 6 groups, as done 
in the Hematological and soft 
tissue neoplasms, there was 
increased incidence of cancers during 9-10 yrs and more than 10 yrs (7 cases 33.33%) followed by 2-3 yrs and less than 2 
yrs (3 cases, 14.29%) 
 Incidence is common in Males (12 cases 57.14%) as in soft tissue and hematological neoplasms when compared with 
females (9 cases 42.86 %). 
 
 
 
 
 
 
Table No-10 
 
SL.
NO 
PERIOD TOTAL 
NO.OF CNS 
NEOPLASMS 
PAEDIATRIC 
CANCERS 
PERCENTAGE 
1 JAN 2003 – DEC 2003 
 18 5 27.78 % 
2 JAN 2004 – DEC 2004 
 21 5 23.80 % 
3 JAN 2005 – DEC 2005 
 32 11 34.37 % 
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SL.NO AGE MALE FEMALE TOTAL 
NO.OF 
CASES 
PERCENTAGE
1 ≤ 2 
 
1 2 3 14.29 % 
2 3 – 4 
 
3 - 3 14.29 % 
3 5 – 6 
 
1 - 1 4.76 % 
4 7 – 8 
 
- - - - 
5 9 – 10 
 
3 4 7 33.33 % 
6 ≥ 10 
 
4 3 7 33.33 % 
 
 
The following Table No. 11 shows Paediatric CNS - Neoplasm distribution. 
 
Table – 11 
 
SL.NO CNS TUMOURS NO.OF 
CASES
PERCENTAGE AGE 
1 MEDULLOBLASTOMA/PNET 8 38.09 % 4 – 11 
yrs 
2 EPENDYMOMA 
 
3 14.29 % 2 – 5 
yrs 
3 ASTROCYTOMA 7 33.33 % 2 – 14 
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yrs 
4 CHORDOMA 
 
1 4.76 % 3 yrs 
5 PINEOBLASTOMA/PINEOCYTOMA
 
2 9.52 % 9 -15 
yrs 
 
Medulloblastoma / PNET (Fig.20&Fig.21) predominates with [8 cases (38. 09%)], in the age group of 4-11 yrs 
followed by Astrocytomas, (Fig.22, Fig.23 &Fig.24)  [7 cases (33. 33%)] and ependymomas [3 cases (14.29%)]. 
 2 cases of Pineoblastoma / Pineocytoma (Fig.25&Fig.26)   and one case of chordoma at the age of 9-15 yrs and 3 yrs 
were also observed. 
 
SPECIAL STUDIES: 
 
In 2 cases of Acute Myeloid leukemia & 11 cases of lymphoproliferative lesions, histochemistry and Sudan black B 
(Fig.27 to Fig.31)   was done and the results were given in the following. 
Table - 12 
 
SL.NO PERIPHERAL.SMEAR 
NUMBER 
SUDAN 
BLACK B 
PAS RESULTS 
1 PS 1501/05 
 
POSITIVE NEGATIVE AML 
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2 PS 1404/05 
 
NEGATIVE POSITIVE ALL 
3 PS 1395/05 
 
NEGATIVE POSITIVE ALL 
4. PS 2096/05 
 
NEGATIVE POSITIVE ALL 
5 PS 1494/05 
 
POSITIVE NEGATIVE AML 
 
IMMUNO HISTOCHEMISTRY: 
 
 Immunohistochemical stains GFAP and CD Markers – for  Astrocytomas and Hodgkin Lymphomas  was also 
undertaken and the results were given in the following Table No-13 (Fig.32 to Fig.42).   
 
Table No - 13. 
 
SL.NO IHC MARKER RESULT IMPRESSION 
1 HODGKIN LYMPHOMA CD-30 NEGATIVE NON-HODGKIN 
LYMPHOMA 
2. NON-HODGKIN 
LYMPHOMA 
  
1.LARGE CELL  
   LYMPHOMA 
 
 
2. LARGE CELL        
   LYMPHOMA 
 
 
 
PAN-B 
MARKER 
CD20 
 
PAN-T 
MARKER 
 
 
 
POSITIVE 
 
 
 
POSITIVE 
 
 
 
 
DIFFUSE LARGE B 
CELL LYMPHOMA  
 
DIFFUSE LARGE T 
CELL LYMPHOMA 
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3. LARGE CELL        
   LYMPHOMA 
 
 
4. LARGE CELL        
   LYMPHOMA 
 
CD3 
 
PAN-T  
MARKER 
CD3 
 
PAN-B 
MARKER 
CD20 
 
 
POSITIVE 
 
 
 
POSITIVE 
 
DIFFUSE  
LARGE T CELL 
LYMPHOMA 
 
DIFFUSE  
LARGE B CELL 
LYMPHOMA 
3 CENTRAL NERVOUR 
SYSTEM NEOPLASM 
 
ASTROCYTOMA-GRADE 
III 
 
 
 
 
 
 
 
 
 
 
 
 
ASTROCYTOMA-GRADE 
II -III 
 
 
GLIOBLASTOMA 
MULITIFORME 
GRADE -IV 
 
 
 
 
 
 
GFAP 
VIMENTIN 
EMA 
 
 
SMA  
 
 
 
 
DESMIN 
 
GFAP 
 
 
 
 GFAP 
 
 
 
 
 
 
 
 
POSITIVE(+++) 
POSITIVE(+++) 
POSITIVE(+++) 
SCATTERED 
CELLS 
POSITIVE(+++) 
IN VESSELS AND 
VERY FEW 
TUMOUR CELLS 
NEGATIVE 
 
POSITIVE(++) IN 
TUMOUR CELLS 
 
POSITIVE(++) 
 
 
 
 
 
ATYPICAL TERATOID 
RHABDOID TUMOUR 
 
 
 
 
 
 
 
 
GRADE II  
 
 
 
GRADE II 
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DISCUSSION 
Although cancer among children is relatively uncommon, it remains a significant cause of mortality in this 
population and is second only to accidents as a cause of death in the age group of 5 - 14 years. 
 
 The Incidence of Paediatric cancer is increasing, in comparison with studies conducted by various research workers 
and literature. In our study, the incidence of Paediatric hematological malignancies is 44.49%, which is in correlation with 
studies conducted by Elizabeth J. Rosen MD. Resident Physician.37,43,53,75 The average incidence of hematological Paediatric 
Malignancy is 1 in 630, and the relative rate of hematological cancer below 5 yrs is 40%. 
 
 In Western Population, the increased incidence of hematological malignancies is observed below the age of 5 
years.7,13,29  
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In our study, the Peak incidence of hematological Malignancies is seen after 10 yrs, followed by 3-4 yrs, which is in 
contrast with the studies conducted by western research workers. 
Probably related to low socio economic status, Poor education and lack of knowledge regarding the initial alarming 
symptoms of hematological Malignancies. 
 The most common hematological neoplasm in children is leukemia and it also stands as most common malignancy. 
 
 In our study, acute lymphoblastic leukemia is the commonest hematological neoplasm followed by lymphoma / 
lymphoproliferative disorders, which is well in correlation with literature. 
 
 In doubtful cases, use of histochemistry with Sudan – black B and PAS allows an initial, standard cost effective 
method, helpful in arriving at diagnosis. 
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 One case of Hodgkin lymphoma, with total effacement of architecture and Polymorphous population of lymphocytes 
with few RS like cells, when subjected to IHC with CD Marker CD 30, a classical RS cell marker revealed total negative 
staining for RS cells, and positive for - B cell markers of NHL. 
 
 Lymphomas comprise approximately 24.44% of all paediatric malignancies, making them the third most common 
cancer.50,51,56,57 Approximately 60% of paediatric lymphomas are non-Hodgkin's lymphoma (NHL). Boys are affected more 
often than girls with a 3:1 ratio and the peak incidence of NHL is between the ages of 7 and 11 years. 
 
 
 Histologic varieties of NHL are divided into low-, intermediate-, or high-grade categories bases upon their clinical 
behavior and over 90% of children have high-grade disease at presentation.39,40,41 High-grade lesions include,  
Large cell lymphomas constitute about 27% of paediatric NHL. 
 Lymphoblastic lymphoma occurs in 29% of paediatric cases. 
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 The small cell noncleaved lymphomas are found in 34% of paediatric NHL and Burkitt's lymphoma (BL) is the most 
common of this subtype.  
 
 The evaluation of the child suspected to have a lymphoma begins, of course, with a complete history and physical. 
Definitive diagnosis requires tissue for pathologic evaluation, which may be obtained by a tonsillectomy or open biopsy of 
an involved lymph node. Because most paediatric patients with NHL present with disseminated disease, a complete staging 
work-up must be undertaken. This would include laboratory studies (to include LDH, LFT's and HIV), LP with CSF 
analysis, bilateral iliac crest bone marrow biopsy, CT of the chest, abdomen and pelvis, and bone scan. The reasoning for 
such an extensive work up is that accurate clinical staging is of utmost importance in assigning patients to an appropriate 
treatment protocol. 
 Hodgkin' disease (HD) is less common in the paediatric population than NHL. This occurring in children under the 
age of 10 years. Boys are affected more frequently than girls (3:1) although this ratio narrows after puberty (1.4: 1). 
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 There are four histologic subtypes of HD- nodular sclerosing, mixed cellularity, lymphocyte predominance and 
lymphocyte depletion. Overall, nodular sclerosing and mixed cellularity are the most common subtypes of HD, but in the 
paediatric population the lymphocyte predominance and nodular sclerosing are seen most frequently.4,11,14,22,61 
 
      HD will present with asymmetric lymph node enlargement in about 90% of cases. The lymphadenopathy is described 
as firm, rubbery and non-tender and in the neck most often involves the supraclavicular fossa. The most common 
extralymphatic site of HD is the spleen, followed by the liver. Nearly one-third of patients will have associated 
constitutional symptoms at presentation including fever, night sweats, anorexia, weakness or loss of 10% or more of body 
weight.  
 
 
 
 
Neuroblastoma being the most common abdominal-soft tissue neoplasm, observed in our study, as studies conducted 
by various research workers. 
 Neuroblastoma is the most common extra cranial solid tumor of childhood and accounts for 8-10% of childhood 
cancers. The annual incidence of these tumors is around 9 cases / 1,000,000 in children under 15 years of age. It is the most 
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common malignancy in children under 1 year of age and 90-95% of patients ill present before the age of 10 years. 
Neuroblastoma is slightly more common in boys than girls.  
 The cell of origin for neuroblastoma is the neural crest cell that eventually gives rise to the sympathetic nervous 
system. These tumors may develop from the paraspinal sympathetic ganglia, the adrenal chromaffin cells within the adrenal 
medulla or other various intra-abdominal paraganglia. Histologically, neuroblastoma is one of several "small blue round 
cell" tumors that occur in children and must be differentiated from other similar tumors such as Ewing's sarcoma, NHL, 
Primitive neuroectodermal tumors and undifferentiated soft-tissue sarcomas. This differentiation is aided by the use of 
immunohistochemical staining in which neuroblastoma will be positive for neurofilament proteins, synaptophysin and 
neuron-specific enclose. 
 
 The majority of primary neuroblastomas present as an intra-abdominal mass involving the adrenal gland or 
retroperitoneal paraganglia.12,21,35,68 
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 The criteria necessary to make a diagnosis of neuroblastoma as established by the International Neuroblastoma 
Staging System includes either a definitive histologic diagnosis on light microscopy +/- immunohistochemistry, electron 
microscopy or the presence of elevated urine catecholamines, or a bone marrow biopsy demonstrating unequivocal tumor 
cells and the presence of elevated urine catecholamines. The metastatic work up for neuroblastoma is to that for other 
paediatric malignancies and includes chest x-ray, bilateral iliac crest bone marrow biopsy, bone scan, CT or MRI of the 
neck and abdomen. 
 A variety of staging systems for neuroblastoma exist that take into account tumor burden, surgical resectability and 
metatatic disease, The TNM criteria define Stage I disease as primary tumor <5cm with no regional or distant disease. Stage 
II includes tumors >5cm but <10cm with no regional or distant disease. Stage III includes tumors up to 10cm plus regional 
disease or tumors over 10cm +/- regional disease but without distant disease. Stage IV is defined as cases with a single 
primary tumor +/- regional disease and presence of distant disease. And finally, Stage V includes multicentric primary 
tumor +/- regional or distant disease.      
 
 
 Ewing sarcoma & ovarian neoplasms constitute second most common -soft tissue neoplasms. 
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 Ewing sarcoma (ES) and primitive neuroectodermal tumour (PNET) are rare sarcomas of bone and soft tissue, 
described in 1921 by Dr. James Ewing and in 1918 by Dr. Arthur Purdy Stout, respectively.5,67 Although ES and PNET 
were originally regarded as totally separate entries, this distinction began to blur with the description by Angervali and 
Enzinger in 1975 of an “extra skeletal neoplasm resembling Ewing’s sarcoma” and the 1984 report of jaffe et al of “the 
neuroectoderminal tumour of bone”.5,67,46,47 It has subsequently been established that both ES and PNET share in over 90% 
of cases a balanced translocation (11; 22) (q24; q12), and they are now almost universally regarded as ends of a common 
histologic spectrum, known as the “Ewing family of tumours” (EFTs). 
 Both ES and PNET are “small round blue cell tumours” which lack obvious differentiation by light microscopy and 
which are composed of nearly indifferent, primitive-appearing cells at the ultra structural level. Thus, the diagnosis of EFT 
has traditionally been one of exclusion, although this situation has improved considerably over the last 10 years with the 
introduction of much better immunohisochemical markers of EFT, such as CD99 and FLII protein. 
 
 The histologic features of typical ES include a sheet-like to vaguely lobular growth pattern, well-developed capillary 
vasculature, and uniform cell population of round cells approximately two times the size of an endothelial cell, with a small 
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amount of lightly eosinophilic cytoplasm, regular nuclear contours, finely dispersed chromatin, and in apparent or small 
nucleoli. Geographic necrosis and individual degenerating cells (so-called “dark cells”) were also frequently present. 
In this study, Hepatoblastoma, Retinoblastoma and colorectal - adenocarcinomas each constitute – 8.33% of cases. 
 
Hepatoblastoma usually forms a single mass, is often very large when first detected and may weigh over 1000g. The 
tumor has a variegated appearance according to the proportion of its histologic components (i.e. brown to green, fibrous or 
calcified) and often shows areas of necrosis, cystic change and hemorrhage. Vascularity is usually prominent, a thin capsule 
may be present and the rest of the liver is normal.  
  The most recent classification recognizes six subtypes of hepatoblastoma: epithelial (fetal, embryonal and fetal, 
macrotrabecular, small cell) and mixed epithelial-mesenchymal (with or without teratoid features). Teratoid 
hepatoblastomas may contain squamous epithelium, neural and melanocytic cells and endocrine components which are not 
found in developing or normal adult livers. The majority of hepatoblastomas consist of liver epithelial cells in various stages 
of development and a mesenchymal component that is usually spindle celled or osteoid. The epithelial component may be 
of   several types, the presence of two or more being required for the diagnosis. Embryonal type cells are smaller, elongated 
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or fusiform, and darkly staining. They have hyperchromatic nuclei and little cytoplasm. They may aggregate into rosette-
like clusters or appear as cords or ribbons but seldom as tubules. Fetal-type cells are polygonal and relatively large, almost 
the size of normal liver cells. They have round to oval nuclei and single nucleoli, the cytoplasm may be granular or clear, 
depending on the amount of glycogen and fat. These cells are generally organized into irregular plates with bile canaliculi 
and sinusoids. Extramedullary hemopoiesis is commonly seen.   
 
 
Hepatic tumors account for approximately 1% of child malignancies, with hepatoblastoma (HB) and hepatocellular 
carcinoma (HCC) constituting the majority.32,54 Because of their rarity, generalizations regarding the epidemiology are 
difficult. Worldwide, HB occurs almost twice as often as HCC in children. 
 
Male predominance has been pointed out in the report of Chen et al. and our study disclosed a similar result.32,54 
 
 Routine newborn screening by paediatrician with physical exam is the only way to find the abdominal mass but it is 
always too late for high stages. In the paediatric  literature,  several  cases   have  been  diagnosed   post-natally,    within   
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6 weeks after delivery, suggesting that HB may arise during fetal life. But only a case report could be found about antenatal 
diagnosis of congenital HB in uterus as initial presentation of enlarged fetal abdominal circumference at 36 weeks of 
gestation. Now, the prenatal sonogram is prevalent and may help to an early diagnosis of liver tumors. 
 
Retinoblastoma is the most common intraocular tumor in childhood3,25,8  and the most common tumor of the retina, 
but it is a rare malignant tumor with a prevalence of about 1 / 23,000 live births. 
 
Common presenting features included a fungating mass prolapsed through a corneal perforation, proptosis caused by 
posterior orbital involvement, bulphthalmos from secondary glaucoma, neurologic manifestations related to intracranial 
involvement, and enlarged preauricular or submandibular lymph nodes from metastasis. 
 
The abnormal appearance of one or both pupils. The pupil usually appears white (leukocoria). Strabismus can be 
present in 35% of the patients. Computed tomography aids in determining the size and location of the retinoblastoma, and 
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can be used to detect macroscopic extra ocular extension; microscopic spread within the optic nerve beyond the lamina 
cribrosa is not readily detectable with CT. 
 
In the pathologic examination, the gross features of intraocular retinoblastoma are dependent on the growth pattern of 
the tumor. Five growth patterns are recognized: endophytic, exophytic, mixed endophytic-exophytic, diffuse infiltrating and 
complete spontaneous regression. Histopathologically, retinoblastomas are essentially malignant neuroblastic tumors that 
may arise in any of the nucleated retinal layers. The predominant cell is small with large basophilic nuclei of variable size 
and shape, and scanty cytoplasm. Mitotic figures are typically numerous. Especially in large tumors, sleeves of viable cells 
are present along dilated blood vessels. If the tumor cells are displaced more than 90-110.m from the vessel, they often 
undergo ischemic necrosis. The formation of Flexner-Winter Steiner rosettes is highly characteristic of retinoblastomas and 
they are found within areas of undifferentiated malignant cells exhibiting mitotic activity.  
 
The typical Flexner-Winter Steiner rosettes are lined by tall cuboidal cells with basally located nuclei that 
circumscribe an apical lumen. Homer wright rosettes are less common in retinoblastoma than Flexner-Winter Steiner 
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rosettes.     Because they are found in a variety of neuroblastic tumors, they are less specific for retinoblastoma. In these 
rosettes, cells are not arranged about a lumen but instead send out cytoplasmic processes that form a tangle within the center 
of the rosette.  
 
Rhabdomyosarcoma are malignant neoplasms which show morphologic, immunohistochemical, ultra structural or 
molecular genetic evidence of primary skeletal muscle differentiation, usually in the absence of any other pattern of 
differentiation. 
 
Rhabdomysarcoma falls into three main groups - embryonal, alveolar and pleomorphic - and, in general terms, the 
forst two groups occur mainly in children, while pure pleomorphic lesions occur almost exclusively in adult. 
Rhabdomyosarcoma in children occurs principally before the age of 10 years, with a peak before the age of 4 years, and 
shows a moderate male predominance. The most common sites are the head and neck region45,46,47  (including orbit and 
meninges), followed by the genitourinary tract, followed by the limbs, and then the trunk.  
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As a general rule, embryonal lesions affect somewhat younger patients than the alveolar type, the latter being more 
frequent in adolescents; limb tumors are much more commonly alveolar than embryonal. Two other infrequent, but 
distinctive, clinical traits in alveolar rhabdomyosarcoma are the tendency to develop breast metastases in female patients 
and to present very rarely in a manner closely resembling leukemia due to extensive bone marrow involvement, without a 
clearly evident primary lesion. This latter pattern of disease may well represent malignant transformation of bone marrow 
mesenchymal stem cells ("rhabdomyoblastemia").  
 
Embryonal rhabdomyosarcoma, which accounts for around 60% of childhood cases, in its classical form consists of 
small, round or spindle-shaped, undifferentiated (basophilic) cells, admixed with variable numbers of round, strap-or 
tadpole-shaped eosinophilic rhabdomyoblasts, in a myxoid stroma. Cytoplasmic cross-striations are present in no more than 
20-30% of cases but, even in tumors with almost no discernible rhabdomyoblasts, desmin or muscle actin immunostains are 
positive in more than 95% of cases and this is therefore the most reliable means of making the diagnosis in the routine 
setting.  
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There have been considerable recent advance in molecular genetic means of confirming and refining the diagnosis of 
rhabdomyosarcoma and, particularly in paediatric oncology centers, this is becoming the standard of care.  
 
Overall, the diagnosis of small round cell tumors in young patients has been transformed during the past twenty 
years. Immunohistochemistry and, more recently, molecular genetics have largely superceded hematoxylin and eosin 
morphology in this context since in general; they are more consistently discriminatory as is essential in the setting of 
significantly different treatment protocols.  
 
Soft tissue sarcoma occur with an annual incidence of 8.4 cases/million white children younger than 15yrs of age 
incidence in black children is 50% of that white children.54,59,65 
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Malignancies of the kidney (renal cancers) represented 6.3% of cancer diagnosis among children younger than 15 
years of age (incidence 7.9 per million) and 4.4% of cancer diagnosis for children and adolescents younger than 20 years of 
age (incidence of 6.2 per million). 
 
 
Wilms' tumor was by far the most common form of renal cancer in children. Wilms' tumor occurred most commonly 
among children younger than 5 years of age, with very low incidence for 10-14 and 15-19 year olds. The highest incidence 
for Wilms' tumor was in the first 2 years of life, followed by steadily decreasing rates with increasing age.26,58,69 
 
In our study, Osteosarcoma constitutes about 6.25% of cases. Osteosarcoma can be defined simply as a malignant 
tumor in which osteoid or bony matrix is produced by the tumor cells. Osteosarcomas can be subdivided broadly into two 
groups; the majority occurs within the bone but a small minority occurs on the surface. These two broad categories can be 
further subdivided depending on the clinical, roentgenographic, and histologic features. 
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Conventional osteosarcoma is a high-grade malignant tumor that occurs predominantly in the metaphysis of the long 
bones of children. Most osteosarcomas occur in adolescents and young adults. It is unusual to see an osteosarcoma in a 
patient younger than 5 years or older than 50 years unless there is a predisposing condition. There is a definite male 
predominence. The majority of conventional osteosarcomas have their epicenter in the metaphysis of a long bone. 
Approximately 10% occur in the shaft of the bone. 
 
 A small percentage of osteosarcoma occurs in the flat bones, such as pelvic bones and scapula. These may be related 
to previous irradiation or a pre-existing condition such as Paget's disease. Involvement of the bones of the hands and feet is 
even more uncommon. 
 
 The clinical symptoms are quite non-specific. Patients complain of pain or swelling or both of variable duration, 
ranging from days to months. Pathologic fracture may be the initial symptom. 
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 The roentgenographic features of osteosarcoma are quite variable. The tumor usually gives rise to a large area of 
destruction of bone with extension into soft tissue. The amount of mineral present in the lesion varies and correlates 
somewhat with the type of osteosarcoma. As the tumor destroys the cortex, it lifts up the periosteum. This results in reactive 
new bone formation at the junction between the elevated periosteum and the underlying cortex. This is referred to as 
Codman's triangle. Rarely, an osteosarcoma is small and extremely well circumscribed, suggesting a benign lesion. 
 
 The gross appearance of osteosarcoma also   is quite variable. Most have the fish-flesh appearance associated with 
sarcomas. Some are heavily mineralized and hence extremely hard. Some have large areas of obvious blue cartilage. 
 Microscopically, most osteosarcomas are highly malignant tumors; their spindle cells have nuclei with marked 
pleomorphism. Conventional osteosarcoma can be further subdivided into osteoblastic, chondroblastic, and fibroblastic 
varieties, depending on the predominant matrix. 
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 Approximately half of all osteosarcomas can be called "osteoblastic". Characteristically, the matrix is produced as a 
fine network between individual tumor cells. The matrix may be in the form of unmineralized osteoid or may show 
mineralized trabeculae. 
 
 In our study malignant mixed germ cell tumours and gonadoblastoma constitute about 10.42 % of cases. 
 
 Malignant mixed germ cell tumours occur in children and young woman. Mixed germ cell tumours tend to be large, 
average size 15 cm in diameter. Their gross appearance depends on which elements are present. Elements of yolk sac 
tumour vary in colour, contain cystic and firm cartilaginous or bony foci.6,24 Areas of choriocarcinoma are hemorrhagic and 
necrotic. Mixed germ cell tumours are ordinarily unilateral but, when dysgerminoma is present they can be bilateral. 
 
  
There are two malignant elements in 80 % of mixed germ cell tumours and four or more in the reminder. The 
elements can be mixed together or they can grow in separate but contiguous foci. Dysgerminoma is the most frequent 
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element, followed by yolk sac tumour and immature teratoma. Embryonal carcinoma, choriocarcinoma and polyembryoma 
are rarely found. 
 
Gonadoblastoma is a rare tumour that arises almost exclusively in abnormal gonads and contains an admixture of 
germ cells and sex cord cells. 
 
 The average age at diagnosis is 18 years, and 80% of gonadoblastomas are detected before the age of 20 years.  Most 
gonadoblastomas are found when a patient is evaluated for primary or secondary amenorrhea or for an abnormally formed 
genital tract.   
 
 Gonadoblastoma arises in abnormal gonads, including streak gonads, indeterminate gonads, and dysgenetic testes. It 
is typically small, ranging from microscopic to 2-3 cm in diameter.  More than 40% of cases are bilateral.  The cut surface is 
tan or white and often contains calcified areas. 
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Microscopically, nests of germ cells and sex cord cells are surrounded by fibrous stroma.  The germ cells resemble 
dysgerminoma cells.  They are large and polygonal with abundant clear cytoplasm, vesicular nuclei and prominent nucleoli.  
Sex cord cells surround the germ cells.  These resemble granulose cells, or more commonly, Sertoli cells.  They surround 
one or more germ cells or small spaces containing eosinophilic hyaline material.  The stroma surrounding a gonadoblastoma 
frequently is luteinized in postpubertal patients and it may contain microcalcifications.  Immunostains for inhibin, vimentin, 
and cytokeratin are positive in the sex cord elements.  The hyaline material reacts with antilaminin antibodies. 
 
 In our study, Paediatric CNS Neoplasm constitutes about 15.90% with Peak age at presentation during 9-10years and 
more than 10yrs. These figures are in contrast with hematological and soft tissue neoplasm in which most of the cases are 
seen in < 5yrs of age. The Incidence is also slightly higher in Males, with M:F of 1.3 : 1. In our study, medulloblastoma is 
the commonest childhood neoplasm which is in correlation with the data provided by the National Cancer Institute as well 
as the study conducted by the various research workers and authors.2,10,20,66 
 
Two major risk group categories defined by clinical criteria are now being used: 
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 AVERAGE RISK: Children older than 3 years with posterior fossa tumors; tumor is totally or near-totally (<1.5 cc's of 
residual disease) resected; no dissemination. 
POOR RISK: Children 3 years old or younger or those with metastatic disease and/or subtotal resection (>1.5 cc's of 
residual disease) and/or nonposterior fossa location.    
 
  Astrocytomas constitute about 33.33% of cases in which 3 cases goes difficulty on diagnosis at light macroscopy 
level. With Immunohistochemical marker, GFAP 2 cases of grade-II anaplastic astrocytoma yielded positive result where as 
one case of anaplastic astrocytoma showed positivity for  EMA and vimentin in association to GFAP and final impression 
of Atypical teratoid /   rhabdiod tumor was made. 
 
 Pineoblastoma / pineocytomas constitute about 9.52 % of cases.Second most common tumour in the pineal region. 
Pineoparenchymal tumours arises from pinocytes. Pineoblastoma occurring predominately is childhood.  Pineoblastoma is 
the most malignant variant and is considered a subgroup of PNETS of childhood. 
 
 93
 Consist of sheets of crowded highly anaplastic neoplastic cells that appear undifferentiated they manifest local 
nuclear molding with a high mitotic rate resembling that a melulloblastoma (or) PNET and retinoblastoma.42,46 
 
 
 Flexer wintersteiner rosettes can be identified.  In some tumours intermixed area containing features from 
pineocytoma, pineal parenchymal tumours of intermediate malignancy and  pineoblastoma can be identifited pineoblastoma 
cannots increased malignancy and is high grade. 
 
 It shows mixed photoreceptor and neuro endocrine features immunoperoxidase for synaptophysin identifies their 
neuronal phenotype.  Other markers such as chromogranin, tau, neurofilament, neuron specific enolase are sometime used.  
But less reliable than synaptophysin.  Retinal S antigen reactivity reflects their photosensory differentiation. 
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CONCLUSION 
 
In general, because of early detection and progress with therapeutic methods, mortality due to malignant diseases as a 
whole during childhood has been decreasing. Although mortality from all cancers in children fell in recent years, the 
incidence of childhood brain tumors is increasing. 
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 In the present prospective study of 132 cases of Paediatric cancers evaluated with clinical light microscopy 
Histochemical and IHC, following conclusions are made and presented. 
1. The average incidence of Paediatric malignant neoplasm is 2 %. 
2. The incidence of Paediatric neoplasms are in increasing trend with new  
     modalities of investigating procedures. 
3. No classical epidermiological or socioeconomic cause is identified as an  
      etiological feature in Paediatric cancers. 
4. Paediatric cancers are common in Male children with Male to Female ratio of 1.5:1 
5. The peak age of paediatric neoplasm is less than 5yrs of age.  
6. Hematological malignancy acute lymphoblastic leukemia is the commonest neoplasm in childhood. 
 
7. Histochemical stains shall have their value in differentiating acute leukemias. 
8. In all cases of lymphoma, final confirmation with CD marker for treatment and prognosis is the gold standard 
strategy / method. 
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9. Neuroblastoma is the most common neoplasm following leukemia. 
10. Rare tumors like colorectal adenocarcinoma Melanoma and nasopharyngeal  
     carcinoma are also occur even in Paediatric age groups. 
11. Primary CNS neoplasms are relatively rare in children, in contrast with  
     Western population where brain tumors are common near to leukemia. 
12. In case of doubtful histogenesis, Immunohistochemistry is very useful for final diagnosis. 
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APPENDIX-VI 
 
IMMUNO- HISTOCHEMISTRY 
 
Method Used: 
 
1. 5µ thick sections were cut from the blocks received (diagnosed as lymphomas) on slides coated with Chrome alum 
gelatin. 
2. Slides were dewaxed and dehydrated in graded alcohol. 
3. Slides were immersed in 0.3 % H2O2 for 20 minutes to block endogenous peroxidase activity. 
4. Washed in phosphate buffered saline (PBS). 
5. Incubated in Primary Antibody & Pan B (CD20, clove L26 DAKO),  PAN T (CD3, polyclonal, DAKO), (CD30, 
clove L26 DAKO) & GFAP for 20 minutes. 
6. Washed in PBS. 
7. Biotinylated link was applied for 20 minutes. 
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8. Washed in PBS. 
9. Incubated in streptavin-biotin complex. 
10. Washed in PBS. 
11. DAB was used as chromagen. 
12. Washed and canbe stained with haematoxylin. 
13. Mounted with coverslip 
Control run – was tonsil. 
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 CHART 
 
 
SL.NO 
 
HPE/PS 
 
AGE 
(Years) 
 
SEX 
 
CLINICAL 
PRESENTATION 
 
DIAGNOSIS 
 
SPECIAL 
STAINS 
 
IMMUNO 
HISTOCHEMISTRY 
1 351/03 5 M Axillary Node NHL – Large cell Lymphoma Not done Not done 
2 666/03 12 M Intra abdominal mass  NHL-Large cell Lymphoma Not done CD20 - Positive 
3 794/03 15 M Lymph Node Biopsy NHL- Lymphoblastic Lymphoma Not done Not done 
4 1232/03 9 F Sub mental node biopsy NHL- Large cell Lymphoma Reticulin -Positive Not done 
5 1840/03 12 M Lymph Node Biopsy Hodgkin lymphoma - Mixed cellularity Not done Not done 
6 2067/03 3 M Lymph Node Biopsy NHL- Large cell Lymphoma Reticulin -Positive CD3 - Positive 
7 266/04 5 M Lymph Node Biopsy NHL- Large cell Lymphoma Not done Not done 
8 939/04 8 F Ileocaecal intussusception 
Lymph Node 
NHL-Burkitt's Lymphoma  
 
Not done Not done 
9 1030/04 15 F Lymph Node Biopsy NHL- Burkitt’s Lymphoma Not done Not done 
10 2296/04 15 M Lymph Node Biopsy 
 
Hodgkin’s lymphoma Not done Not done 
11 2663/04 10 M Inguinal Lymph Node NHL- Large cell Lymphoma Reticulin -Positive CD20 - Positive 
12 2684/04 2 M Lymph Node Biopsy NHL- large cell  Lymphoma Not done Not done 
13 79/05 6 M Cervical Lymph Node NHL- large cell Lymphoma Not done Not done 
14 80/05 3 F Lymph Node from Ileum NHL- Diffuse large cell lymphoma Not done CD3 - Positive 
15 466/05 6 M Right- cervical Node NHL Large cell Lymphoma Reticulin -Positive Not done 
16 780/05 5 F Cervical Lymphoma NHL Large cell Lymphoma Not done Not done 
17 1348/05 11 F Cervical lymph Node Lympho proliferative disorder  Not done Not done 
18 519/05 15 M Cervical Lymph Node Hodgkin’s Lymphoma Not done CD30 - Negative 
19 PS40/05 10 F Anaemia,Hepatomegaly Lympho proliferative disorder Not done Not done 
20 PS235/05 3 M Hepatomegaly, fever, 
Anaemia 
ALL Not done Not done 
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21 PS987/05 4 M Anaemia, Generalized Lymphadenopathy  Lympho proliferative disorder Not done Not done 
22 PS1230/05 3 M Hepatomegaly, fever, Anaemia ALL-L2 Not done Not done 
23 PS1341/05 7 F Hepatosplenomegaly, Fever, Anaemia ALL Not done Not done 
24 PS2096/05 14 M Hepatosplenomegaly, Fever, Anaemia ALL-L2 PAS - Positive Not done 
25 PS2122/05 14 F Anaemia, Generalized Lymphadenopathy Lympho proliferative disorder Not done Not done 
26 PS2158/05 14 M Fever, Bleeding Manifestation, Joint Pain Lymphoma spill Not done Not done 
27 PS2519/05 3 M Hepatosplenomegaly, Fever, Anaemia ALL-L1 Not done Not done 
28 PS1501/05 9 F Gum Hypertrophy. Bony tenderness, 
fever 
AML-M4 Sudan BlackB 
Positive 
Not done 
29 PS1494/05 2 M Splenomegaly. Bony tenderness, fever AML Sudan BlackB 
Positive 
Not done 
30 PS1404/05 13 F Anaemia,Hepatomegaly ALL PAS - Positive Not done 
31 PS1395/05 8 M Hepatosplenomegaly, Fever, Anaemia ALL PAS - Positive Not done 
32 PS906/05 5 M Generalized lymphadenopathy, Bony 
tenderness. 
Lympho proliferative disorder Not done Not done 
33 PS1386/05 14 M Fever, upper respiratory track infection Lymphoma Spill Not done Not done 
34 PS359/05 13 F Fever, bleeding manifestation, anaemia Lymphoma Spill Not done Not done 
35 PS207/04 4 F Joint pain, upper respiratory infection, 
fever 
ALL Not done Not done 
36 PS368/04 3 F Anaemia, fever, hepatosplenomegaly ALL-L1-2 Not done Not done 
37 PS392/04 10 M Anaemia, fever, hepatosplenomegaly ALL-L1 Not done Not done 
38 PS447/04 11 M Anaemia, fever, hepatosplenomegaly ALL-L2 Not done Not done 
39 PS568/04 15 M Bleeding manifestation, anaemia Lymphoma spill Not done Not done 
40 PS645/04 9 M Hepatosplenomegaly, 
fever 
ALL-L2 Not done Not done 
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41 PS666/04 8 F Generalized 
Lymphadenopathy,fever 
Lymphoproliferative disorder Not done Not done 
42 PS840/04 2 M Bleeding manifestation, anaemia Lymphoma spill Not done Not done 
43 PS868/04 5 M Hepatosplenomegaly, 
fever 
ALL-L1 Not done Not done 
44 PS996/04 10 M Fever , anaemia, splenomegaly ALL Not done Not done 
45 PS1059/04 4 M Splenomegaly, fever, anaemia ALL Not done Not done 
46 PS1220/04 5/12 M Anaemia,Hepatomegaly ALL-L1 Not done Not done 
47 PS1247/04 14 M Anaemia, fever, hepatosplenomegaly ALL-L2 Not done Not done 
48 PS1354/04 5 F Hepatomegaly , fever, Anaemia ALL-L2 Not done Not done 
49 PS1358/04 4 M Fever, upper respiratory track infection Lymphoma spill Not done Not done 
50 PS1359/04 4 M Joint pain, upper respiratory infection, 
fever 
ALL Not done Not done 
51 PS1389/04 5 F Anaemia, fever, hepatosplenomegaly ALL Not done Not done 
52 PS1539/04 15 M Generalized 
Lymphadenopathy,fever 
Lympho proliferative 
disorder 
Not done Not done 
53 PS1563/04 9 M Hepatomegaly, fever, Anaemia ALL-L1 Not done Not done 
54 PS1742/04 13 M Anaemia, fever, hepatosplenomegaly ALL Not done Not done 
55 PS1767/04 11 F Splenomegaly, fever, anaemia ALL Not done Not done 
56 PS52/03 9 M Splenomegaly, fever, anaemia ALL Not done Not done 
57 PS155/03 5 F Anaemia, fever, hepatosplenomegaly ALL Not done Not done 
58 PS182/03 7 F Splenomegaly, fever, anaemia ALL Not done Not done 
59 PS207/03 7 F Joint pain, upper respiratory infection, 
fever 
ALL Not done Not done 
60 PS366/03 5 M Anaemia, fever, hepatosplenomegaly ALL Not done Not done 
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61 PS460/03 13 M Splenomegaly, Bony tenderness, fever ALL-L2 Not done Not done 
62 PS981/03 11 M Splenomegaly, fever, anaemia ALL Not done Not done 
63 PS572/03 7 M Splenomegaly, fever, anaemia ALL-L2 Not done Not done 
64 175/03 3 M Growth oral cavity Malignant melanoma Not done Not done 
65 177/03 11 F Colonic growth Well differentiated Adeno 
carcinoma 
Not done Not done 
66 511/03 15 F Ovarian mass Dysgerminoma Not done Not done 
67 786/03 13 M Naso pharyngeal growth Well differentiated   
Squamous cell carcimona 
Not done Not done 
68 866/03 2 M Thoracic mass Neuroblastoma Not done Not done 
69 1251/03 8 F Adrenal mass Ganglioneuroblastoma/ 
Composit neuroblastoma 
Not done Not done 
70 1657/03 12 F Sarcoma from Anus MFH with Storiform - 
Pleomorphic type 
Not done Not done 
71 1771/03 3 F Ovarian cyst Gonodoblastoma Not done Not done 
72 1870/03 4 F Rt Adrenal mass Adrenal cortical carcinoma Not done Not done 
73 97/04 2 F Swelling in Rt Gluteal region Small round cell type Not done Not done 
74 118/04 3 M Rt Adrenal mass Neuroblastoma Not done Not done 
75 237/04 13 F Anal growth Mucinous adeno Carcinoma Not done Not done 
76 853/04 4 F Lt orbit prolapsed eye Retinoblastoma Not done Not done 
77 892/04 12 M Recurrent growth Previous report 
schwannoma 
Low grade MPNST Not done Not done 
78 1058/04 10 M Chest wall tumor Extra skeletal Ewings 
sarcoma 
Not done Not done 
79 1306/04 3 M Testicular tumor Mixed germ cell tumor 
(Embryonal carcinoma,yolk 
sac) 
Not done Not done 
80 1715/04 1 F Lt calf Spindle cell variant of 
Rhabdomyosarcoma 
Not done Not done 
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81 2039/04 10 M Recto sigmoid annular growth Well differentiated  adenocarcinoma  Not done Not done 
82 17/05 3 F Presacral teratoma Mixed germ cell tumor  
(Yolk sac, teratoma) 
Not done Not done 
83 21/05 15 M Distal femur Osteosarcoma Not done Not done 
84 206/05 5 F Lt growth nasal cavity Embryonal Rhabmyosarcoma Not done Not done 
85 222/05 5 F Left Eye Retinoblastoma Not done Not done 
86 253/05 15 F Left tibia anterolateral aspect Osteosarcoma Not done Not done 
87 779/05 11 F Ovarian tumor 
Mass abdomen 
Mixed germ cell tumor Not done Not done 
88 860/05 15 M Rt knee swelling Osteosarcoma Not done Not done 
89 864/05 3 M Liver biopsy Hepatoblastoma Not done Not done 
90 865/05 10 M Biopsy growth Extra skeletal Ewing’s Sarcoma Not done Not done 
91 869/05 4 M Kidney Wilm’s tumor Not done Not done 
92 950/05 6 F Biopsy Extra skeletal Ewing’s Sarcoma Not done Not done 
93 1122/05 1 F Mass Right Lumbar region 
Right adrenal Tumor  
Ganglioneuroblastoma 
 
Not done Not done 
94 1123/05 3 M Biopsy Ewing’s Sarcoma Not done Not done 
95 1562/05 9 M Adrenal tumor Neuroblastoma Not done Not done 
96 1888/05 15 M Sarcoma Mesenchymal Malignant NerveSheath 
tumor 
Not done Not done 
97 1943/05 4 M Adrenal tumor Neuroblastoma Not done Not done 
98 2040/05 3 M Right eye Retinoblastoma Not done Not done 
99 2235/05 15 M Mass nasophrenia Nasopharyngeal  carcinoma - lympho 
epithelioma type 
Not done Not done 
100 2420/05 4 M Right eye Retinoblastoma Not done Not done 
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101 2236/05 15 M Laryngeal Papilloma High grade SIL with focal area of invasion Not done Not done 
102 123/05 3 F Ovarian tumor Gonodoblastoma Not done Not done 
103 27/05 6 F Biopsy Ewing’s Sarcoma Not done Not done 
104 126/05 4 F Ovarian tumor Monodermal teratoma Not done Not done 
105 286/05 2 M Left testicular tumor Embryonal Rhabdomyosarcoma Not done Not done 
106 471/05 30 days M Liver biopsy Hepatoblastoma Not done Not done 
107 472/05 4 months M Abdominal mass Neuroblastoma – Undifferentiated type Not done Not done 
108 581/05 30 days F Liver Hepatoblastoma Not done Not done 
109 957/06 4 F Liver Hepatoblastoma Not done Not done 
110 1059/05 7 F Adrenal Neuroblastoma -Undifferentiated type Not done Not done 
111 1224/06 15 M Superficial parotidectomy Low grade Muco epidermoid carcinoma. Not done Not done 
112 270/03 4 M Posterior fossa tumor Medulloblastoma with area of necrosis Not done Not done 
113 1064/03 5 M Frontal lobe abscess Medullo epithelioma/ Ependymoma Not done Not done 
114 1131/03 14 M Suboccipital Anaplastic Astrocytoma Not done Not done 
115 1605/03 2 F Left Parietal Craniotomy Ependymoma with extensive calcification Not done Not done 
116 1698/03 2 F SOL Ependymoma Not done Not done 
117 248/04 4 M Left Temporo Parietal lesion PNET Not done Not done 
118 788/04 3 M Neuroepithelial tumor Dedifferentiated Chordoma Not done Not done 
119 1513/04 2 M Frontal SOL Grade III Astrocytoma Not done GFAP Positive 
120 1686/04 10 F Posterior fossa tumor Medulloblastoma Not done Not done 
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121 2610/04 9 M Posterior fossa tumor Medulloblastoma Not done Not done 
122 29/05 11 F Supra sellar SOL  Astrocytoma – Grade III Not done Not done 
123 36/05 15 F Right frontal glioma Astrocytoma  –  Grade III Not done Not done 
124 406/05 11 F Posterior fossa occupying 
lesion 
Medulloblastoma Not done Not done 
125 897/05 9 F Posterior fossa occupying 
lesion 
Medulloblastoma Not done Not done 
126 1551/05 11 M Right temporoparietal 
subcortical SOL 
Atypical Teratoid / Rhabdoid tumour Not done GFAP, EMA, 
VIMENTIN, SMA, 
DESMIN - Positive 
127 1657/05 10 F Post fossa SOL Medulloblastoma -Desmoplastic 
variant 
Not done Not done 
128 2507/05 10 F Lt frontal cystic lesion  Astrocytoma –  Grade III Not done GFAP - Positive 
129 56/05 15 M Lt Pineal SOL Pinecytoma/ Pineal parenchymal tumor Not done Not done 
130 610/06 9 M Posterior fossa tumor Medulloblastoma/PNET Not done Not done 
131 1164/06 15 M Pineal SOL Pineocytoma Not done Not done 
132 1121/05 9 M Frontoparietal region Astrocytoma –  Grade III Not done Not done 
 
